Biogen Pulls Plug on Alzheimer’s Drug Aduhelm
Wall Street Journal
The company says it will continue to advance another drug, Leqembi, and accelerate the development of other treatments.
https://www.wsj.com/articles/biogen-ends-aduhelm-program-in-shift-of-alzheimers-resources-163c897a